ProAssurance FY2025 EPS Estimate Lowered by Zacks Research

ProAssurance Co. (NYSE:PRA - Free Report) - Analysts at Zacks Research cut their FY2025 earnings per share estimates for shares of ProAssurance in a research note issued on Tuesday, May 27th. Zacks Research analyst K. Dey now anticipates that the insurance provider will post earnings of $0.88 per share for the year, down from their prior estimate of $0.91. The consensus estimate for ProAssurance's current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance's Q1 2026 earnings at $0.21 EPS, Q2 2026 earnings at $0.24 EPS and FY2026 earnings at $1.05 EPS.

ProAssurance (NYSE:PRA - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The insurance provider reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). ProAssurance had a return on equity of 2.65% and a net margin of 3.71%. The business had revenue of $236.28 million for the quarter, compared to analyst estimates of $272.85 million. During the same period last year, the firm posted $0.08 EPS. ProAssurance's quarterly revenue was down 4.5% on a year-over-year basis.

A number of other equities analysts have also recently issued reports on PRA. Citizens Jmp cut ProAssurance from an "outperform" rating to a "market perform" rating in a report on Thursday, April 3rd. Raymond James lowered shares of ProAssurance from a "market perform" rating to an "underperform" rating in a report on Thursday, April 10th. Piper Sandler boosted their target price on shares of ProAssurance from $18.00 to $25.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Wall Street Zen initiated coverage on shares of ProAssurance in a report on Monday, May 19th. They set a "hold" rating on the stock. Finally, Citigroup lowered shares of ProAssurance to a "market perform" rating in a report on Thursday, April 3rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $21.00.

ProAssurance Price Performance

Shares of ProAssurance stock traded up $0.02 during trading on Friday, reaching $23.21. 255,695 shares of the company's stock were exchanged, compared to its average volume of 456,060. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. ProAssurance has a 1-year low of $10.76 and a 1-year high of $23.70. The company has a market cap of $1.19 billion, a P/E ratio of 27.96 and a beta of 0.04. The firm's 50-day moving average price is $23.15 and its 200 day moving average price is $18.45.

Institutional Investors Weigh In On ProAssurance

Institutional investors have recently made changes to their positions in the stock. Wealthfront Advisers LLC bought a new stake in shares of ProAssurance in the 4th quarter valued at about $359,000. Deutsche Bank AG grew its stake in ProAssurance by 50.1% during the fourth quarter. Deutsche Bank AG now owns 47,679 shares of the insurance provider's stock worth $759,000 after purchasing an additional 15,921 shares during the period. Amundi increased its holdings in ProAssurance by 182.3% in the fourth quarter. Amundi now owns 25,634 shares of the insurance provider's stock worth $389,000 after purchasing an additional 16,552 shares in the last quarter. Northern Trust Corp increased its holdings in ProAssurance by 3.1% in the fourth quarter. Northern Trust Corp now owns 559,694 shares of the insurance provider's stock worth $8,905,000 after purchasing an additional 16,983 shares in the last quarter. Finally, Prudential Financial Inc. increased its holdings in ProAssurance by 57.3% in the fourth quarter. Prudential Financial Inc. now owns 86,703 shares of the insurance provider's stock worth $1,379,000 after purchasing an additional 31,580 shares in the last quarter. Institutional investors own 85.58% of the company's stock.

About ProAssurance

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.